Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-106621
Filing Date
2024-09-16
Accepted
2024-09-16 09:04:43
Documents
80
Period of Report
2024-07-31

Document Format Files

Seq Description Document Type Size
1 6-K ipa-20240731.htm   iXBRL 6-K 251277
2 EX-99.1 ipa-ex99_1.htm EX-99.1 445044
3 EX-99.2 ipa-ex99_2.htm   iXBRL EX-99.2 1893888
4 EX-99.3 ipa-ex99_3.htm EX-99.3 23967
5 EX-99.4 ipa-ex99_4.htm EX-99.4 22401
6 GRAPHIC img36100363_0.jpg GRAPHIC 8744
7 GRAPHIC img37023884_0.jpg GRAPHIC 8744
  Complete submission text file 0000950170-24-106621.txt   11913667

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ipa-20240731.xsd EX-101.SCH 1359190
82 EXTRACTED XBRL INSTANCE DOCUMENT ipa-20240731_htm.xml XML 3154629
Mailing Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8
Business Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 241299486
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)